A pilot study of respiratory muscle training to improve cough effectiveness and reduce the incidence of pneumonia in acute stroke: study protocol for a randomized controlled trial

Stefan Tino Kulnik, Gerrard Francis Rafferty, Surinder S Birring, John Moxham, Lalit Kalra, Stefan Tino Kulnik, Gerrard Francis Rafferty, Surinder S Birring, John Moxham, Lalit Kalra

Abstract

Background: After stroke, pneumonia is a relevant medical complication that can be precipitated by aspiration of saliva, liquids, or solid food. Swallowing difficulty and aspiration occur in a significant proportion of stroke survivors. Cough, an important mechanism protecting the lungs from inhaled materials, can be impaired in stroke survivors, and the likely cause for this impairment is central weakness of the respiratory musculature. Thus, respiratory muscle training in acute stroke may be useful in the recovery of respiratory muscle and cough function, and may thereby reduce the risk of pneumonia. The present study is a pilot study, aimed at investigating the validity and feasibility of this approach by exploring effect size, safety, and patient acceptability of the intervention.

Methods/design: Adults with moderate to severe stroke impairment (National Institutes of Health Stroke Scale (NIHSS) score 5 to 25 at the time of admission) are recruited within 2 weeks of stroke onset. Participants must be able to perform voluntary respiratory maneuvers. Excluded are patients with increased intracranial pressure, uncontrolled hypertension, neuromuscular conditions other than stroke, medical history of asthma or chronic obstructive pulmonary disease, and recent cardiac events. Participants are randomized to receive inspiratory, expiratory, or sham respiratory training over a 4-week period, by using commercially available threshold resistance devices. Participants and caregivers, but not study investigators, are blind to treatment allocation. All participants receive medical care and stroke rehabilitation according to the usual standard of care. The following assessments are conducted at baseline, 4 weeks, and 12 weeks: Voluntary and reflex cough flow measurements, forced spirometry, respiratory muscle strength tests, incidence of pneumonia, assessments of safety parameters, and self-reported activity of daily living. The primary outcome is peak expiratory cough flow of voluntary cough, a parameter indicating the effectiveness of cough. Secondary outcomes are incidence of pneumonia, peak expiratory cough flow of reflex cough, and maximum inspiratory and expiratory mouth pressures.

Discussion: Various novel pharmacologic and nonpharmacologic approaches for preventing stroke-associated pneumonia are currently being researched. This study investigates a novel strategy based on an exercise intervention for cough rehabilitation.

Trial registration: Current Controlled Trials ISRCTN40298220.

Figures

Figure 1
Figure 1
Flowchart of study design.

References

    1. Hannawi Y, Hannawi B, Rao CPV, Suarez JI, Bershad EM. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35:430–443. doi: 10.1159/000350199.
    1. Royal College of Physicians. National Sentinel Stroke Audit Phase II (Clinical Audit) London: Royal College of Physicians; 2009.
    1. Royal College of Physicians. National Sentinel Stroke Clinical Audit 2010 Round 7. London: Royal College of Physicians; 2011.
    1. Wilson RD. Mortality and cost of pneumonia after stroke for different risk groups. J Stroke Cerebrovasc Dis. 2012;21:61–67. doi: 10.1016/j.jstrokecerebrovasdis.2010.05.002.
    1. Saposnik G, Hill MD, O’Donnell M, Fang J, Hachinski V, Kapral MK. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke. 2008;39:2318–2324. doi: 10.1161/STROKEAHA.107.510362.
    1. Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR. the GAIN International Steering Committee and Investigators. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol. 2004;11:49–53. doi: 10.1046/j.1468-1331.2003.00749.x.
    1. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D, Saposnik G. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology. 2011;77:1338–1345. doi: 10.1212/WNL.0b013e31823152b1.
    1. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Janzen RWC, Rother J, Buecker-Nott HJ, Berger K. for The German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med. 2004;164:1761–1768. doi: 10.1001/archinte.164.16.1761.
    1. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. for the Stroke Practice Improvement Network Investigators. Formal dysphagia screening protocols prevent pneumonia. Stroke. 2005;36:1972–1976. doi: 10.1161/01.STR.0000177529.86868.8d.
    1. Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW. The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology. 2003;60:620–625. doi: 10.1212/01.WNL.0000046586.38284.60.
    1. Koennecke HC, Belz W, Berfelde D, Endres M, Fitzek S, Hamilton F, Kreitsch P, Mackert BM, Nabavi DG, Nolte CH, Pöhls W, Schmehl I, Schmitz B, Von Brevern M, Walter G, Heuschmann PU. for the Berlin Stroke Register Investigators. Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology. 2011;77:965–972. doi: 10.1212/WNL.0b013e31822dc795.
    1. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis. 2006;15:209–213. doi: 10.1016/j.jstrokecerebrovasdis.2006.05.004.
    1. Sellars C, Bowie L, Bagg J, Sweeney MP, Miller H, Tilston J, Langhorne P, Stott DJ. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke. 2007;38:2284–2291. doi: 10.1161/STROKEAHA.106.478156.
    1. Tong X, Kuklina EV, Gillespie C, George MG. Medical complications among hospitalizations for ischemic stroke in the United States from 1998 to 2007. Stroke. 2010;41:980–986. doi: 10.1161/STROKEAHA.110.578674.
    1. Vernino S, Brown RD, Sejvar JJ, Sicks JD, Petty GW, O’Fallon WM. Cause-specific mortality after first cerebral infarction: a population-based study. Stroke. 2003;34:1828–1832. doi: 10.1161/01.STR.0000080534.98416.A0.
    1. Hong K, Kang D, Koo J, Yu K, Han M, Cho Y, Park J, Bae H, Lee B. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol. 2008;15:1324–1331. doi: 10.1111/j.1468-1331.2008.02310.x.
    1. Katzan IL, Dawson NV, Thomas CL, Votruba ME, Cebul RD. The cost of pneumonia after acute stroke. Neurology. 2007;68:1938–1943. doi: 10.1212/01.wnl.0000263187.08969.45.
    1. Christensen MC, Valiente R, Sampaio Silva G, Lee WC, Dutcher S, Guimaraes Rocha MS, Massaro A. Acute treatment costs of stroke in Brazil. Neuroepidemiology. 2009;32:142–149. doi: 10.1159/000184747.
    1. Chumbler NR, Williams LS, Wells CK, Lo AC, Nadeau S, Peixoto AJ, Gorman M, Boice JL, Concato J, Bravata DM. Derivation and validation of a clinical system for predicting pneumonia in acute stroke. Neuroepidemiology. 2010;34:193–199. doi: 10.1159/000289350.
    1. Hoffmann S, Malzahn U, Harms H, Koennecke H, Berger K, Kalic M, Walter G, Meisel A, Heuschmann PU. Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke. Stroke. 2012;43:2617–2623. doi: 10.1161/STROKEAHA.112.653055.
    1. Lakshminarayan K, Tsai AW, Tong X, Vazquez G, Peacock JM, George MG, Luepker RV, Anderson DC. Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke. 2010;41:2849–2854. doi: 10.1161/STROKEAHA.110.597039.
    1. Smithard DG, O’Neill PA, Park C, Morris J, Wyatt R, England R, Martin DF. Complications and outcome after acute stroke: does dysphagia matter? Stroke. 1996;27:1200–1204. doi: 10.1161/01.STR.27.7.1200.
    1. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke. 2005;36:2756–2763. doi: 10.1161/01.STR.0000190056.76543.eb.
    1. National Collaborating Centre for Chronic Conditions. Stroke: National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack. London: TIA; 2008.
    1. Bath PMW, Bath-Hextall FJ, Smithard D. Interventions for dysphagia in acute stroke. Cochrane Database Syst Rev. 1999;4 CD000323.
    1. Geeganage C, Beavan J, Ellender S, Bath PMW. Interventions for dysphagia and nutritional support in acute and subacute stroke. Cochrane Database Syst Rev. 2012;10:000323.
    1. Perry L, Love CP. Screening for dysphagia and aspiration in acute stroke: a systematic review. Dysphagia. 2001;16:7–18. doi: 10.1007/PL00021290.
    1. Langdon PC, Lee AH, Binns CW. Dysphagia in acute ischaemic stroke: severity, recovery and relationship to stroke subtype. J Clin Neurosci. 2007;14:630–634. doi: 10.1016/j.jocn.2006.04.009.
    1. Holas MA, DePippo KL, Reding MJ. Aspiration and relative risk of medical complications following stroke. Arch Neurol. 1994;51:1051–1053. doi: 10.1001/archneur.1994.00540220099020.
    1. Masiero S, Pierobon R, Previato C, Gomiero E. Pneumonia in stroke patients with oropharyngeal dysphagia: a six-month follow-up study. Ital J Neurol Sci. 2008;29:139–145. doi: 10.1007/s10072-008-0925-2.
    1. Johnson ER, McKenzie SW, Sievers A. Aspiration pneumonia in stroke. Arch Phys Med Rehabil. 1993;74:973–976.
    1. Ramsey D, Smithard D, Kalra L. Silent aspiration: what do we know? Dysphagia. 2005;20:218–225. doi: 10.1007/s00455-005-0018-9.
    1. Addington WR, Stephens R, Widdicombe J, Rekab K. Effect of stroke location on the laryngeal cough reflex and pneumonia risk. Cough. 2005;1:4. doi: 10.1186/1745-9974-1-4.
    1. Addington WR, Stephens RE, Gilliland KA. Assessing the laryngeal cough reflex and the risk of developing pneumonia after stroke: an interhospital comparison. Stroke. 1999;30:1203–1207. doi: 10.1161/01.STR.30.6.1203.
    1. Smith Hammond CA, Goldstein LB, Horner RD, Ying J, Gray L, Gonzalez-Rothi L, Bolser DC. Predicting aspiration in patients with ischemic stroke: comparison of clinical signs and aerodynamic measures of voluntary cough. Chest. 2009;135:769–777. doi: 10.1378/chest.08-1122.
    1. Smith Hammond CA, Goldstein LB, Zajac DJ, Gray L, Davenport PW, Bolser DC. Assessment of aspiration risk in stroke patients with quantification of voluntary cough. Neurology. 2001;56:502–506. doi: 10.1212/WNL.56.4.502.
    1. Ickenstein GW, Riecker A, Höhlig C, Müller R, Becker U, Reichmann H, Prosiegel M. Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept. J Neurol. 2010;257:1492–1499. doi: 10.1007/s00415-010-5558-8.
    1. Westendorp WF, Vermeij J, Vermeij F, Den Hertog HM, Dippel DWJ, van de Beek D, Nederkoorn PJ. Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev. 2012;1:008530.
    1. Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9:1187–1200. doi: 10.1586/ern.09.72.
    1. Widdicombe JG, Addington WR, Fontana GA, Stephens RE. Voluntary and reflex cough and the expiration reflex; implications for aspiration after stroke. Pulm Pharmacol Ther. 2011;24:312–317. doi: 10.1016/j.pupt.2011.01.015.
    1. Zhou Z, Vincent F, Salle J, Antonini M, Aliamus V, Daviet J. Acute stroke phase voluntary cough and correlation with maximum phonation time. Am J Phys Med Rehabil. 2012;91:494–500. doi: 10.1097/PHM.0b013e31824fa66a.
    1. Yoon J, Park J, Lee D, Roh H. Comparisons of respiratory function and activities of daily living between spinal cord injury and stroke patients and normal elderly people. J Phys Ther Sci. 2011;24:465–469.
    1. Harraf F, Ward K, Man W, Rafferty G, Mills K, Polkey M, Moxham J, Kalra L. Transcranial magnetic stimulation study of expiratory muscle weakness in acute ischemic stroke. Neurology. 2008;71:2000–2007. doi: 10.1212/01.wnl.0000336927.30977.56.
    1. Ward K, Seymour J, Steier J, Jolley CJ, Polkey MI, Kalra L, Moxham J. Acute ischaemic hemispheric stroke is associated with impairment of reflex in addition to voluntary cough. Eur Respir J. 2010;36:1383–1390. doi: 10.1183/09031936.00010510.
    1. Syabbalo N. Assessment of respiratory muscle function and strength. Postgrad Med J. 1998;74:208–215. doi: 10.1136/pgmj.74.870.208.
    1. Reid WD, Dechman G. Considerations when testing and training the respiratory muscles. Phys Ther. 1995;75:971–982.
    1. Goldstein RS. Pulmonary rehabilitation in chronic respiratory insufficiency. 3. Ventilatory muscle training. Thorax. 1993;48:1025–1033. doi: 10.1136/thx.48.10.1025.
    1. Polkey MI, Green M, Moxham J. Measurement of respiratory muscle strength. Thorax. 1995;50:1131–1135. doi: 10.1136/thx.50.11.1131.
    1. Pollock RD, Rafferty GF, Moxham J, Kalra L. Respiratory muscle strength and training in stroke and neurology: a systematic review. Int J Stroke. 2013;8:124–130. doi: 10.1111/j.1747-4949.2012.00811.x.
    1. Yousheng X, Man L, Jin W, Hongye L. Inspiratory muscle training for the recovery of function after stroke. Cochrane Database Syst Rev. 2012;5 CD009360.
    1. Britto RR, Rezende NR, Marinho KC, Torres JL, Parreira VF, Teixeira-Salmela L. Inspiratory muscular training in chronic stroke survivors: a randomized controlled trial. Arch Phys Med Rehabil. 2011;92:184–190. doi: 10.1016/j.apmr.2010.09.029.
    1. Sutbeyaz ST, Koseoglu F, Inan L, Coskun O. Respiratory muscle training improves cardiopulmonary function and exercise tolerance in subjects with subacute stroke: a randomized controlled trial. Clin Rehabil. 2010;24:240–250. doi: 10.1177/0269215509358932.
    1. NIH Stroke Scale.
    1. Reid WD, Samral B. Respiratory muscle training for patients with chronic obstructive pulmonary disease. Phys Ther. 1995;75:996–1005.
    1. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol. 1985;58:1776–1782.
    1. Gladman JRF, Lincoln NB, Adams SA. Use of the Extended ADL Scale with stroke patients. Age Ageing. 1993;22:419–424. doi: 10.1093/ageing/22.6.419.
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi: 10.1183/09031936.05.00034805.
    1. American Thoracic Society (ATS) and European Respiratory Society (ERS) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518–624.
    1. Singh P, Murty GE, Mahajan RP, Knights D, Aitkenhead AR. The tussometer: accuracy and reproducibility. Br J Anaesth. 1994;73:145–148. doi: 10.1093/bja/73.2.145.
    1. Sheskin DJ. Parametric and Nonparametric Statistical Procedures. London: CRC Press; 1997.
    1. Day SJ, Graham DF. Sample size and power for comparing two or more treatment groups in clinical trials. BMJ. 1989;299:663–665. doi: 10.1136/bmj.299.6700.663.
    1. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123–1124. doi: 10.1136/bmj.323.7321.1123.
    1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Appl Stat B. 1995;57:289–300.
    1. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi: 10.1002/sim.4067.
    1. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55. doi: 10.1093/biomet/70.1.41.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi: 10.1136/bmj.c332.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869.
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295–309. doi: 10.7326/0003-4819-148-4-200802190-00008.
    1. Mann G, Hankey GJ, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke. 1999;30:744–748. doi: 10.1161/01.STR.30.4.744.
    1. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–140. doi: 10.1016/0196-6553(88)90053-3.
    1. Bott J, Blumenthal S, Buxton M, Ellum S, Falconer C, Garrod R, Harvey A, Hughes T, Lincoln M, Mikelsons C, Potter C, Pryor J, Rimington L, Sinfield F, Thompson C, Vaughn P, White J. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64:i1–i52. doi: 10.1136/thx.2008.110726.
    1. Little RJ, D’Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367:1355–1360. doi: 10.1056/NEJMsr1203730.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit